WDR26 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.693000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.016000E-01
Normal-vs-Stage2
3.206600E-01
Normal-vs-Stage3
1.080420E-01
Normal-vs-Stage4
9.289800E-01
Stage1-vs-Stage2
6.957000E-01
Stage1-vs-Stage3
3.418600E-01
Stage1-vs-Stage4
1.279550E-01
Stage2-vs-Stage3
2.088800E-01
Stage2-vs-Stage4
2.078200E-01
Stage3-vs-Stage4
6.160100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.301400E-01
Normal-vs-AfricanAmerican
8.691200E-01
Normal-vs-Asian
3.991000E-01
Caucasian-vs-AfricanAmerican
1.667370E-01
Caucasian-vs-Asian
8.782600E-01
AfricanAmerican-vs-Asian
3.510600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.613000E-01
Normal-vs-Female
1.733030E-01
Male-vs-Female
4.640400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.928800E-01
Normal-vs-Age(41-60Yrs)
5.909000E-01
Normal-vs-Age(61-80Yrs)
1.961630E-01
Normal-vs-Age(81-100Yrs)
8.246300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.923000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.672600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.453800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.718200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.396400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.593200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.068000E-01
Normal-vs-Daily Drinker
4.908000E-02
Normal-vs-Weekly Drinker
4.286400E-01
Normal-vs-Occasional Drinker
7.775600E-01
Normal-vs-Social Drinker
4.882000E-01
Non Drinker-vs-Daily Drinker
5.738300E-02
Non Drinker-vs-Weekly Drinker
7.723200E-01
Non Drinker-vs-Occasional Drinker
9.762400E-02
Non Drinker-vs-Social Drinker
3.625600E-01
Daily Drinker-vs-Weekly Drinker
1.050410E-01
Daily Drinker-vs-Occasional Drinker
3.920000E-03
Daily Drinker-vs-Social Drinker
2.101600E-02
Weekly Drinker-vs-Occasional Drinker
3.337400E-01
Weekly Drinker-vs-Social Drinker
6.703400E-01
Occasional Drinker-vs-Social Drinker
5.348600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.549030E-01
Normal-vs-Grade 2
7.419200E-03
Normal-vs-Grade 3
1.172190E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.036100E-02
Grade 1-vs-Grade 3
1.411820E-02
Grade 1-vs-Grade 4
1.549030E-01
Grade 2-vs-Grade 3
3.555200E-01
Grade 2-vs-Grade 4
7.419200E-03
Grade 3-vs-Grade 4
1.172190E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.055200E-01
Normal-vs-NonDiabetic
2.420600E-01
Diabetic-vs-NonDiabetic
4.484400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.593190E-01
Normal-vs-NoPancreatitis
2.536200E-01
Pancreatitis-vs-NoPancreatitis
8.356600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.107800E-01
Normal-vs-N1
2.575200E-01
N0-vs-N1
7.180000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.534000E-01
Normal-vs-TP53-NonMutant
2.951200E-01
TP53-Mutant-vs-TP53-NonMutant
2.098400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
